Clinical Trials Browser

Phase 3 × Lung Neoplasms × cediranib × Clear all

NCT00795340 2023-08-22

Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 3 Completed

306 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms